Welcome to our dedicated page for Southstate Corporation SEC filings (Ticker: SSB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Credit-quality tables, CECL reserve swings, and net-interest margin math can turn SouthState’s filings into a 300-page maze. If you have ever asked, “Where do I find the SouthState quarterly earnings report 10-Q filing?” or “What’s hidden in the latest SouthState insider trading Form 4 transactions?” you already know the challenge.
Stock Titan solves it. Our AI reads every SouthState SEC document the moment it hits EDGAR, then condenses the essentials—capital ratios, loan portfolio shifts, deposit mix changes—into plain language. Whether you need the SouthState annual report 10-K simplified, a real-time alert for SouthState Form 4 insider transactions, or an 8-K material events explained summary, the platform delivers answers, not page counts.
Jump straight to what matters:
- Instant highlights from each SouthState quarterly earnings report 10-Q filing—track margin trends without spreadsheet gymnastics.
- Real-time dashboards of SouthState executive stock transactions Form 4 so you can monitor insider sentiment before the market reacts.
- Context-rich notes on every SouthState proxy statement executive compensation section, showing pay tied to return on assets and tangible book growth.
- One-click deep dives into SouthState 8-K material events—merger announcements, loan charge-offs, or dividend changes—explained simply.
Analysts use these insights to compare quarter-over-quarter reserve builds, portfolio mix, and community-bank M&A impact. Portfolio managers flag unusual SouthState earnings report filing analysis within minutes. Individual investors rely on our AI for understanding SouthState SEC documents with AI, replacing hours of dense reading with clear, actionable points.
Fennec Pharmaceuticals Inc. (FENC) – Form 144 filing discloses that insider Rostislav Raykov has notified the SEC of his intent to sell up to 10,000 common shares through Morgan Stanley Smith Barney on or after 03 July 2025. At the 30 June 2025 closing price used in the filing, the aggregate market value of the proposed sale is $86,102, equivalent to roughly 0.036 % of the 27.6 million shares outstanding.
The shares stem from recently vested restricted-stock grants acquired on 16 May 2025 (7,570 sh) and 30 June 2025 (2,430 sh). The filing also details that Raykov has already disposed of 46,667 shares between 4 April and 5 June 2025 for total gross proceeds of approximately $295,398.
Rule 144 notices do not guarantee execution, but repeated insider sales within a short window can influence market sentiment. Nevertheless, the cumulative volume over the past quarter plus the planned sale (≈56,667 shares) remains below 0.21 % of outstanding shares, suggesting limited dilution or supply pressure.